drugset / Trial / NCT04229394
2ccPA Study in Patients With Symptomatic Knee Osteoarthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial is designed to determine safety and tolerability as well as the MTD of a single-dose 2ccPA and PK data in symptomatic knee OA.
Timeline
- Start
- 2018-02-13
- Primary completion
- 2021-03-22
- Completion
- 2021-03-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CARBACYCLIC PHOSPHATIDIC ACID | Small molecule | 50 ug | Other |
| Subject | CARBACYCLIC PHOSPHATIDIC ACID | Small molecule | 200 ug | Other |
| Subject | CARBACYCLIC PHOSPHATIDIC ACID | Small molecule | 800 ug | Other |
| Subject | CARBACYCLIC PHOSPHATIDIC ACID | Small molecule | 2400 ug | Other |